SCHEMBL9515549

SCHEMBL9515549

CCCNC(=O)c1ccc(S(=O)(=O)NC(=O)c2ccc(CO)nc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.52
KMT2A Q03164 1/20 0.52
EGFR P00533 5/20 0.48
P4HTM Q9NXG6 4/20 0.47
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
CYP3A4 P08684 1/20 0.44
THRB P10828 1/20 0.44
TSHR P16473 1/20 0.44
NFKB1 P19838 1/20 0.44
HTR2A P28223 1/20 0.44
CYP2C19 P33261 1/20 0.44
ADRA1A P35348 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
FLT1 P17948 2/20 0.44
FLT4 P35916 2/20 0.44
KDR P35968 2/20 0.44
CA2 P00918 1/20 0.43
PTGS2 P35354 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9519322 0.91 CA2 (0.56) KDM4EKMT2AEGFRP4HTMALDH1A1
SCHEMBL9519106 0.91 EGFR (0.50) EGFRP4HTMFLT1FLT4KDR
SCHEMBL9519123 0.89 P4HTM (0.48) KDM4EKMT2AEGFRP4HTMALDH1A1
SCHEMBL9519608 0.88 EGFR (0.44) KDM4EKMT2AEGFRP4HTMALDH1A1
SCHEMBL9517068 0.88 CASP3 (0.47) KDM4EKMT2AP4HTMALDH1A1SMN1; SMN2
SCHEMBL9518026 0.86 HPGD (0.51) KDM4EKMT2AEGFRP4HTMALDH1A1
SCHEMBL9517944 0.85 EGFR (0.49) KMT2AEGFRP4HTMALDH1A1LMNA
SCHEMBL27401721 0.85 MAPT (0.48) KDM4EEGFRP4HTMALDH1A1CYP3A4
SCHEMBL9519310 0.84 EGFR (0.51) EGFRP4HTMALDH1A1FLT1FLT4
SCHEMBL9517947 0.84 NPC1 (0.56) KMT2AALDH1A1LMNANFKB1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 EP disclosed